Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
 
REVIEW ARTICLE
Ahead of Print

Thrombocytosis in gynecological cancers


 Department of Radiation Oncology, VMMC and Safdarjung Hospital, New Delhi, India

Correspondence Address:
Deepti Sharma,
VMMC and Safdarjung Hospital, Room No 264, Second Floor, New OPD Block, New Delhi - 110 029
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Thrombocytosis has been suggested to be a poor prognostic indicator in malignancies. Studies have shown that thrombocytosis is associated with a poor prognosis in various gynecological malignancies such as carcinoma ovary, cervical cancer, and endometrial cancer. The aim of this study is to analyze the impact of thrombocytosis on the prognosis of gynecological cancer. All the relevant data were retrieved by PubMed, MEDLINE, and Web of Science, and then studies were chosen in this analysis of association between thrombocytosis and gynecological malignancy. Thrombocytosis is common in advanced disease in patients with ovarian cancer, endometrial cancer, and cervical cancer. Therefore, it may be a marker of tumor burden or biologically more aggressive disease. Thrombocytosis is bad prognostic factor and associated with poorer outcomes.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Sharma D
    -  Singh G
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed181    
    PDF Downloaded15    

Recommend this journal